PathAI Expands Leadership with Mindpeak, Stratipath Partners
PathAI has expanded its AISight Dx image management system by onboarding AI pathology tools from Mindpeak, Stratipath, and Primaa,...
eClinical Tech News
Semnur, Denali Business Combination Gets Shareholder Approval
Denali Capital Acquisition Corp’s shareholders have approved the merger with Semnur Pharmaceuticals, clearing the way for Semnur—a majority-owned subsidiary...
PathAI Announces Monumental Partnerships to Expand Leadership
PathAI has expanded its AISight DX image management system by integrating AI pathology tools from Mindpeak, Stratipath, and Primaa,...
Connect Biopharma Announces Two Presentations at ERS 2025
Connect Biopharma will present two new analyses of rademikibart, its anti–IL-4Rα monoclonal antibody, at the European Respiratory Society Congress...
Oric Pharma Reports New Inducement Grants Under Nasdaq Rule
ORIC Pharmaceuticals has granted 292,500 non-qualified stock options and 79,000 restricted stock units to a newly hired, non-executive officer...
Amgen’s New Study Reveals Rocatinlimab’s Phase 3 Results
Amgen and Kyowa Kirin released preliminary top-line findings from ASCEND, the long-term extension of their global Phase 3 ROCKET...
Nurexone’s Breakthrough Patent Secures Exosome Supply Chain
Nurexone Biologic has received a US Notice of Allowance for a patent covering its proprietary exosome manufacturing process, built...
EU Approves Oral Semaglutide to Reduce Cardiovascular Death
Novo Nordisk has secured a European label update for Rybelsus (oral semaglutide) to include cardiovascular risk reduction based on...
Harrow Reveals Agenda, Speakers for Investor & Analyst Day
Harrow has set September 26 in New York for its Investor & Analyst Day, previewing a full-throated update across...
INmune Bio’s Successful First Commercial Run of Cordstromâ„¢
INmune Bio has completed its first full-scale pilot commercial manufacturing run of CordSTROM, an off-the-shelf, allogeneic mesenchymal stromal cell...